Singapore markets closed

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.17-0.19 (-2.27%)
At close: 04:00PM EDT
8.22 +0.05 (+0.61%)
Pre-market: 08:27AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
106,394
59,606
3,686
0
0
-
Cost of revenue
7,460
4,987
754
0
0
-
Gross profit
98,934
54,619
2,932
0
0
-
Operating expenses
Research development
98,371
110,575
182,435
145,558
115,308
-
Selling general and administrative
197,021
185,145
122,124
60,971
21,337
-
Total operating expenses
295,392
295,720
304,559
206,529
136,645
-
Operating income or loss
-196,458
-241,101
-301,627
-206,529
-136,645
-
Interest expense
30,150
29,712
15,652
0
0
-
Total other income/expenses net
12,623
11,786
5,821
173
967
-
Income before tax
-213,985
-259,027
-311,458
-206,356
-135,678
-
Income tax expense
3,437
3,113
0
0
-
-
Income from continuing operations
-217,422
-262,140
-311,458
-206,356
-135,678
-
Net income
-217,422
-262,140
-311,458
-206,356
-135,678
-
Net income available to common shareholders
-217,422
-262,140
-311,458
-206,356
-135,678
-
Basic EPS
-4.33
-
-5.66
-4.18
-3.80
-1.20
Diluted EPS
-4.33
-
-5.66
-4.18
-3.80
-1.20
Basic average shares
61,357
-
55,032
49,406
35,668
35,064
Diluted average shares
61,858
-
55,032
49,406
35,668
35,064